Neurocrine Biosciences, Inc.
US ˙ NasdaqGS ˙ US64125C1099

SecurityNBIX / Neurocrine Biosciences, Inc.
InstitutionTIFF INVESTMENT PROGRAM - TIFF Multi-Asset Fund
Latest Disclosed Ownership5,088 shares
Latest Disclosed Value $ 639,510
TIFF INVESTMENT PROGRAM - TIFF Multi-Asset Fund reports 29.49% decrease in ownership of NBIX / Neurocrine Biosciences, Inc.

On August 27, 2025 - TIFF INVESTMENT PROGRAM - TIFF Multi-Asset Fund filed a NPORT-P form disclosing ownership of 5,088 shares of Neurocrine Biosciences, Inc. (US:NBIX) valued at $639,511 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 29, 2025 disclosing 7,216 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of -29.49% during the quarter. The current value of the position is $833,821 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-27 2025-06-30 NP Neurocrine Biosciences EC US64125C1099 5,088 -2,128 -29.49 640 -19.92 0.0455
2025-05-29 2025-03-31 NP Neurocrine Biosciences EC US64125C1099 7,216 -1,011 -12.29 798 -28.88 0.0624
2025-02-28 2024-12-31 NP Neurocrine Biosciences EC US64125C1099 8,227 2,880 53.86 1,123 82.14 0.0856
2024-11-29 2024-09-30 NP Neurocrine Biosciences EC US64125C1099 5,347 730 15.81 616 -2.99 0.0469
2024-08-27 2024-06-30 NP Neurocrine Biosciences EC US64125C1099 4,617 6,515 -343.26 636 -343.30 0.0500
2024-08-27 2024-06-30 NP Neurocrine Biosciences EC US64125C1099 -1,898 0 -0.00 -261 0.00 -0.0206
2024-08-27 2024-06-30 NP Neurocrine Biosciences EC US64125C1099 -1,898 0 -0.00 -261 0.00 -0.0206
2024-08-27 2024-06-30 NP Neurocrine Biosciences EC US64125C1099 -1,898 0 -0.00 -261 0.00 -0.0206
2024-08-27 2024-06-30 NP Neurocrine Biosciences EC US64125C1099 -1,898 -6,515 -141.11 -261 -141.04 -0.0206
2024-05-28 2024-03-31 NP Neurocrine Biosciences EC US64125C1099 4,617 0 0.00 637 4.61 0.0502
2024-02-27 2023-12-31 NP Neurocrine Biosciences EC US64125C1099 4,617 0 0.00 608 17.15 0.0475
2023-11-27 2023-09-30 NP Neurocrine Biosciences EC US64125C1099 4,617 0 0.00 519 19.31 0.0416
2023-08-28 2023-06-30 NP Neurocrine Biosciences EC US64125C1099 4,617 4,617 435 0.0340
2020-02-10 2019-12-31 NP Neurocrine Biosciences EC US64125C1099 0 1,735 -100.00 0 -100.00
2019-11-26 2019-09-30 NP Neurocrine Biosciences EC US64125C1099 -1,735 -1,735 -156 -0.0077
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.